[PHARMA] QoQ Quarter Result on 30-Sep-2023 [#3]

Announcement Date
29-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- -2616.01%
YoY- -672.58%
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 885,486 848,734 880,454 862,720 924,681 761,102 962,174 -5.38%
PBT -56,259 6,342 9,193 -638,395 15,589 4,521 37,439 -
Tax 7,212 -4,018 -6,427 -5,802 -6,212 -3,607 -8,583 -
NP -49,047 2,324 2,766 -644,197 9,377 914 28,856 -
-
NP to SH -49,339 1,961 2,648 -644,390 8,617 722 27,734 -
-
Tax Rate - 63.36% 69.91% - 39.85% 79.78% 22.93% -
Total Cost 934,533 846,410 877,688 1,506,917 915,304 760,188 933,318 0.08%
-
Net Worth -245,740 -137,571 -142,812 -248,894 411,327 406,087 413,947 -
Dividend
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Div - - - - 7,859 6,549 10,479 -
Div Payout % - - - - 91.21% 907.17% 37.79% -
Equity
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Net Worth -245,740 -137,571 -142,812 -248,894 411,327 406,087 413,947 -
NOSH 1,441,229 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 6.61%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -5.54% 0.27% 0.31% -74.67% 1.01% 0.12% 3.00% -
ROE 0.00% 0.00% 0.00% 0.00% 2.09% 0.18% 6.70% -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 65.94 64.78 67.20 65.86 70.59 58.10 73.45 -6.93%
EPS -3.67 0.15 0.20 -49.19 0.66 0.06 2.12 -
DPS 0.00 0.00 0.00 0.00 0.60 0.50 0.80 -
NAPS -0.183 -0.105 -0.109 -0.19 0.314 0.31 0.316 -
Adjusted Per Share Value based on latest NOSH - 1,441,229
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 61.44 58.89 61.09 59.86 64.16 52.81 66.76 -5.38%
EPS -3.42 0.14 0.18 -44.71 0.60 0.05 1.92 -
DPS 0.00 0.00 0.00 0.00 0.55 0.45 0.73 -
NAPS -0.1705 -0.0955 -0.0991 -0.1727 0.2854 0.2818 0.2872 -
Price Multiplier on Financial Quarter End Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 -
Price 0.435 0.37 0.285 0.545 0.515 0.595 0.755 -
P/RPS 0.66 0.57 0.42 0.83 0.73 1.02 1.03 -25.65%
P/EPS -11.84 247.21 141.02 -1.11 78.29 1,079.54 35.66 -
EY -8.45 0.40 0.71 -90.26 1.28 0.09 2.80 -
DY 0.00 0.00 0.00 0.00 1.17 0.84 1.06 -
P/NAPS 0.00 0.00 0.00 0.00 1.64 1.92 2.39 -
Price Multiplier on Announcement Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 29/11/23 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 -
Price 0.405 0.42 0.38 0.44 0.55 0.595 0.72 -
P/RPS 0.61 0.65 0.57 0.67 0.78 1.02 0.98 -27.07%
P/EPS -11.02 280.62 188.02 -0.89 83.61 1,079.54 34.01 -
EY -9.07 0.36 0.53 -111.80 1.20 0.09 2.94 -
DY 0.00 0.00 0.00 0.00 1.09 0.84 1.11 -
P/NAPS 0.00 0.00 0.00 0.00 1.75 1.92 2.28 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment